| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |